Education
About Us
Working with TipRanks
Follow Us
Arbutus Biopharma Corporation (ABUS)
NASDAQ:ABUS
ABUS Analyst Ratings
Moderate Buy
1 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
ABUS Stock 12 Month Forecast
Average Price Target
$7.00
▲(47.37% Upside)
| Highest Price Target$7.00 | Average Price Target$7.00 | Lowest Price Target$7.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Jefferies
$7
Buy
47.37%
Upside
Reiterated
12/11/25
We've written extensively about the cases (primer here). A positive outcome with MRNA would also de-risk the PFE case, which is slightly behind, and which has a larger revenue pool associated with it. judgment will be another catalyst in the near term. judgment and Daubert briefings have just wrapped up.
Citizens JMP
$5
Buy
5.26%
Upside
Reiterated
03/31/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Jefferies
$7
Buy
47.37%
Upside
Reiterated
12/11/25
We've written extensively about the cases (primer here). A positive outcome with MRNA would also de-risk the PFE case, which is slightly behind, and which has a larger revenue pool associated with it. judgment will be another catalyst in the near term. judgment and Daubert briefings have just wrapped up.
Citizens JMP
$5
Buy
5.26%
Upside
Reiterated
03/31/25
Best Analysts Covering Arbutus Biopharma
3 Months
xxx
Success Rate
15/34 ratings generated profit
Average Return
+1.05%
a xxx
rating ―
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 44.12% of your transactions generating a profit, with an average return of +1.05% per trade.
1 Year
Success Rate
20/34 ratings generated profit
Average Return
+10.97%
a rating ―
Copying Roy Buchanan's trades and holding each position for 1 Year would result in 58.82% of your transactions generating a profit, with an average return of +10.97% per trade.
2 Years
xxx
Success Rate
26/34 ratings generated profit
Average Return
+33.94%
a xxx
rating ―
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 76.47% of your transactions generating a profit, with an average return of +33.94% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
ABUS Analyst Recommendation Trends
Rating
Nov 25
Dec 25
Jan 26
Feb 26
Mar 26
Strong Buy
0
0
0
0
0
Buy
0
1
1
1
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
0
1
1
1
0
Each month's total comprises the sum of three months' worth of ratings.
ABUS Financial Forecast
ABUS Stock Forecast FAQ
What is ABUS’s average 12-month price target, according to analysts?
Based on analyst ratings, Arbutus Biopharma Corporation’s 12-month average price target is 7.00.
What is ABUS’s upside potential, based on the analysts’ average price target?
Arbutus Biopharma Corporation has 47.37% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is ABUS a Buy, Sell or Hold?
Arbutus Biopharma Corporation has a consensus rating of Moderate Buy which is based on 1 buy ratings, 0 hold ratings and 0 sell ratings.
What is Arbutus Biopharma Corporation’s price target?
The average price target for Arbutus Biopharma Corporation is 7.00. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $7.00 ,the lowest forecast is $7.00. The average price target represents 47.37% Increase from the current price of $4.75.
The highest analyst price target is $7.00 ,the lowest forecast is $7.00. The average price target represents 47.37% Increase from the current price of $4.75.
What do analysts say about Arbutus Biopharma Corporation?
Arbutus Biopharma Corporation’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 1 Wall Streets Analysts.
How can I buy shares of ABUS?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.